204 related articles for article (PubMed ID: 30738170)
1. New-Onset Post-Transplant Diabetes Mellitus after Allogeneic Hematopoietic Cell Transplant Is Initiated by Insulin Resistance, Not Immunosuppressive Medications.
Engelhardt BG; Savani U; Jung DK; Powers AC; Jagasia M; Chen H; Winnick JJ; Tamboli RA; Crowe JE; Abumrad NN
Biol Blood Marrow Transplant; 2019 Jun; 25(6):1225-1231. PubMed ID: 30738170
[TBL] [Abstract][Full Text] [Related]
2. Metabolic Complications Precede Alloreactivity and Are Characterized by Changes in Suppression of Tumorigenicity 2 Signaling.
Johnpulle RA; Paczesny S; Jung DK; Daguindau E; Jagasia MH; Savani BN; Chinratanalab W; Cornell RF; Goodman S; Greer JP; Kassim AA; Sengsayadeth S; Byrne MT; Engelhardt BG
Biol Blood Marrow Transplant; 2017 Mar; 23(3):529-532. PubMed ID: 28013014
[TBL] [Abstract][Full Text] [Related]
3. New-onset post-transplant diabetes mellitus after haploidentical hematopoietic cell transplant with post-transplant cyclophosphamide.
Mangan BL; Patel D; Chen H; Gatwood KS; Byrne MT; Sengsayadeth S; Goodman S; Dholaria B; Kassim AA; Jagasia M; Chinratanalab W; Culos KA; Engelhardt BG
EJHaem; 2020 Nov; 1(2):576-580. PubMed ID: 33709085
[TBL] [Abstract][Full Text] [Related]
4. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
5. Plasma Branched-Chain Amino Acid Concentrations and Glucose Homeostasis in Kidney Transplant Recipients and Candidates.
Prasad GVR; Nash MM; Yuan W; Beriault D; Yazdanpanah M; Connelly PW
Can J Kidney Health Dis; 2023; 10():20543581231168085. PubMed ID: 37101847
[TBL] [Abstract][Full Text] [Related]
6. The importance of different immunosuppressive regimens in the development of posttransplant diabetes mellitus.
Prokai A; Fekete A; Pasti K; Rusai K; Banki NF; Reusz G; Szabo AJ
Pediatr Diabetes; 2012 Feb; 13(1):81-91. PubMed ID: 21595806
[TBL] [Abstract][Full Text] [Related]
7. How do I manage hyperglycemia/post-transplant diabetes mellitus after allogeneic HSCT.
Fuji S; Rovó A; Ohashi K; Griffith M; Einsele H; Kapp M; Mohty M; Majhail NS; Engelhardt BG; Tichelli A; Savani BN
Bone Marrow Transplant; 2016 Aug; 51(8):1041-9. PubMed ID: 27042848
[TBL] [Abstract][Full Text] [Related]
8. Clinical evolution of post-transplant diabetes mellitus.
Porrini EL; Díaz JM; Moreso F; Delgado Mallén PI; Silva Torres I; Ibernon M; Bayés-Genís B; Benitez-Ruiz R; Lampreabe I; Lauzurrica R; Osorio JM; Osuna A; Domínguez-Rollán R; Ruiz JC; Jiménez-Sosa A; González-Rinne A; Marrero-Miranda D; Macía M; García J; Torres A
Nephrol Dial Transplant; 2016 Mar; 31(3):495-505. PubMed ID: 26538615
[TBL] [Abstract][Full Text] [Related]
9. Early Postoperative Basal Insulin Therapy versus Standard of Care for the Prevention of Diabetes Mellitus after Kidney Transplantation: A Multicenter Randomized Trial.
Schwaiger E; Krenn S; Kurnikowski A; Bergfeld L; Pérez-Sáez MJ; Frey A; Topitz D; Bergmann M; Hödlmoser S; Bachmann F; Halleck F; Kron S; Hafner-Giessauf H; Eller K; Rosenkranz AR; Crespo M; Faura A; Tura A; Song PXK; Port FK; Pascual J; Budde K; Ristl R; Werzowa J; Hecking M
J Am Soc Nephrol; 2021 Aug; 32(8):2083-2098. PubMed ID: 34330770
[TBL] [Abstract][Full Text] [Related]
10. An update review of post-transplant diabetes mellitus: Concept, risk factors, clinical implications and management.
Kanbay M; Copur S; Topçu AU; Guldan M; Ozbek L; Gaipov A; Ferro C; Cozzolino M; Cherney DZI; Tuttle KR
Diabetes Obes Metab; 2024 Jul; 26(7):2531-2545. PubMed ID: 38558257
[TBL] [Abstract][Full Text] [Related]
11. Insulin Secretion and Insulin Resistance Trajectories over 1 Year after Kidney Transplantation: A Multicenter Prospective Cohort Study.
Bang JB; Oh CK; Kim YS; Kim SH; Yu HC; Kim CD; Ju MK; So BJ; Lee SH; Han SY; Jung CW; Kim JK; Lee SH; Jeon JY
Endocrinol Metab (Seoul); 2020 Dec; 35(4):820-829. PubMed ID: 33202516
[TBL] [Abstract][Full Text] [Related]
12. Pretransplantation C-Peptide level predicts early posttransplantation diabetes mellitus and has an impact on survival after allogeneic stem cell transplantation.
Griffith ML; Jagasia MH; Misfeldt AA; Chen H; Engelhardt BG; Kassim A; Savani BN; Survant M; Jagasia SM
Biol Blood Marrow Transplant; 2011 Jan; 17(1):86-92. PubMed ID: 20561594
[TBL] [Abstract][Full Text] [Related]
13. Diabetes mellitus after transplant: relationship to pretransplant glucose metabolism and tacrolimus or cyclosporine A-based therapy.
Sato T; Inagaki A; Uchida K; Ueki T; Goto N; Matsuoka S; Katayama A; Haba T; Tominaga Y; Okajima Y; Ohta K; Suga H; Taguchi S; Kakiya S; Itatsu T; Kobayashi T; Nakao A
Transplantation; 2003 Nov; 76(9):1320-6. PubMed ID: 14627910
[TBL] [Abstract][Full Text] [Related]
14. A 6-year prospective study on new onset diabetes mellitus, insulin release and insulin sensitivity in renal transplant recipients.
Hagen M; Hjelmesaeth J; Jenssen T; Morkrid L; Hartmann A
Nephrol Dial Transplant; 2003 Oct; 18(10):2154-9. PubMed ID: 13679495
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Posttransplantation Diabetes Mellitus After Liver Transplantation: Assessment of Insulin Administration as a Risk Factor.
Linder KE; Baker WL; Rochon C; May ST; Sheiner PA; Martin ST
Ann Pharmacother; 2016 May; 50(5):369-75. PubMed ID: 26847860
[TBL] [Abstract][Full Text] [Related]
16. Mortality risk in post-transplantation diabetes mellitus based on glucose and HbA1c diagnostic criteria.
Eide IA; Halden TA; Hartmann A; Åsberg A; Dahle DO; Reisaeter AV; Jenssen T
Transpl Int; 2016 May; 29(5):568-78. PubMed ID: 26875590
[TBL] [Abstract][Full Text] [Related]
17. Validation of diagnostic utility of fasting plasma glucose and HbA1c in stable renal transplant recipients one year after transplantation.
Ussif AM; Åsberg A; Halden TAS; Nordheim E; Hartmann A; Jenssen T
BMC Nephrol; 2019 Jan; 20(1):12. PubMed ID: 30630438
[TBL] [Abstract][Full Text] [Related]
18. Insulin resistance in kidney allograft recipients treated with calcineurin inhibitors.
Wyzgał J; Paczek L; Sańko-Resmer J; Ciszek M; Nowak M; Rowiński W; Szmidt J; Durlik M
Ann Transplant; 2007; 12(2):26-9. PubMed ID: 18173063
[TBL] [Abstract][Full Text] [Related]
19. Oral Glucose Tolerance Test as a Risk Marker for Developing Post-Transplant Diabetes Mellitus.
Rossi MR; Mazzali M; de Sousa MV
Transplant Proc; 2024 May; ():. PubMed ID: 38762406
[TBL] [Abstract][Full Text] [Related]
20. Early clinical assessment of glucose metabolism in renal allograft recipients: diagnosis and prediction of post-transplant diabetes mellitus (PTDM).
Kuypers DR; Claes K; Bammens B; Evenepoel P; Vanrenterghem Y
Nephrol Dial Transplant; 2008 Jun; 23(6):2033-42. PubMed ID: 18174264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
